Gilead Moves Closer to Filing Novel HIV Combo Afte...
Category : Clinical Trial Update 17 December 2025Gilead Sciences is accelerating toward regulatory submissions for its next-generation HIV treatment...
Gilead Sciences is accelerating toward regulatory submissions for its next-generation HIV treatment...
"While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoi...
Alzheimer’s disease research took an important step forward as Arrowhead Pharmaceuticals dosed...
Roche has released new three-year follow-up findings from its pivotal phase III STARGLO study, offer...
Early-stage ALS research just received a powerful boost. The ALS Association has announced the 2025...